Soros Fund Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Soros Fund Management’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-535,000	Closed	-$9.63M	–	176
2020 Q2	$9.63M	Buy	+535,000	New	+$7.44M	0.21%	65

Soros Fund Management's PTLA Position: Q3 2020 in Review

Soros Fund Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 535,000 shares — an estimated $9.63M sold.

Soros Fund Management first reported a position in PTLA in Q2 2020 and held it in 1 quarter. The position peaked at $9.63M in Q2 2020. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

Soros Fund Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Soros Fund Management sold 535,000 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $9.63M.
Soros Fund Management first reported a position in Portola Pharmaceuticals, Inc. in Q2 2020 and held it in 1 quarter.
Soros Fund Management's Portola Pharmaceuticals, Inc. position peaked at $9.63M in Q2 2020.
0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Soros Fund Management's 13F filing for Q3 2020, filed 13 Nov 2020.